ML18156A453: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
Line 15: Line 15:


=Text=
=Text=
{{#Wiki_filter:EXPORT LICENSE NRC FORM 250 (10-07)UNITED STATES OF AMERICA Nuclear Regulatory Commission Washington, D.C. 20555 NRC LICENSE NO.: XMAT442 Page 1 of 2 NRC DOCKET NO.: 11006299 LICENSE EXPIRES June 30. 2023 Pursuant to the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974 and the regulations of the U.S. Nuclear Regulatory Commission (NRC) issued pursuant thereto, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued to the licensee authorizing the export of the materials and/or production or utilization facilities listed below, subject to the terms and conditions herein.LICENSEE Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston, MA 02210 Attn: Paula Rothwell ULTIMATE CONSIGNEE(S)
{{#Wiki_filter:EXPORT LICENSE NRC FORM 250 (10-07)
IN FOREIGN COUNTRY(IES)
NRC LICENSE NO.:           XMAT442 UNITED STATES OF AMERICA                                                                            Page 1 of 2 Nuclear Regulatory Commission NRC DOCKET NO.:           11006299 Washington, D.C. 20555 LICENSE EXPIRES           June 30. 2023 Pursuant to the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974 and the regulations of the U.S. Nuclear Regulatory Commission (NRC) issued pursuant thereto, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued to the licensee authorizing the export of the materials and/or production or utilization facilities listed below, subject to the terms and conditions herein.
F.I.S. - Fabbrica Italiana Sintetici S.p.A.Viale Milano 26-36075 Montecchio Maggiore (Vicenza)Italy (Manufacture active pharmaceutical ingredients for non-nuclear end use in clinical trials for the treatment of cystic fi brosis)INTERMEDIATE CONSIGNEE(S)
LICENSEE                                           ULTIMATE CONSIGNEE(S)IN FOREIGN COUNTRY(IES)
IN FOREIGN COUNTRY(IES)
Vertex Pharmaceuticals Incorporated                                    F.I.S.- Fabbrica Italiana Sintetici S.p.A.
NONE OTHER PARTY(IES)
50 Northern Avenue                                                    Viale Milano Boston, MA 02210                                                      26-36075 Montecchio Maggiore (Vicenza)
TO EXPORT See Page 2 APPLICANT'S REFERENCE NO.: Appl. date 1/30/18 ULTIMATE DESTINATION(S):
Italy Attn: Paula Rothwell                                                  (Manufacture active pharmaceutical ingredients for non-nuclear end use in clinical trials for the treatment of cystic fibrosis)
Italy QUANTITY(IES) 5,000 kilograms DESCRIPTION OF MATERIAL(S)
INTERMEDIATE CONSIGNEE(S)IN FOREIGN COUNTRY(IES)                                       OTHER PARTY(IES) TO EXPORT NONE                                                                See Page 2 APPLICANT'S REFERENCE NO.: Appl. date 1/30/18                         ULTIMATE DESTINATION(S): Italy QUANTITY(IES)                                         DESCRIPTION OF MATERIAL(S) OR FACILITY(IES) 5,000 kilograms          Deuterium in the form of deuterium gas, deuterium oxide, and deuterium compounds.
OR FACILITY(IES)
THIS LICENSES I^ALID UNLESS SIGNED BELOW Neither this license nor any right under this license shall be                         BY AUTHORIZED N^RpRESENTAT^E assigned or otherwise transferred in violation of the provisions of the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974.                                           SIGNATURE:          (
Deuterium in the form of deuterium gas, deuterium oxide, and deuterium compounds.
This license is subject to the right of recapture or control by Section 108 of the Atomic Energy Act of 1954, as amended, and to NAME AND TITLE        Peter J. t^blghor^Acting Deputy Director all of the other provisions of said Acts, now or hereafter in effect Offi^ of International Programs and to all valid rules and regulations of the NRC.
Neither this license nor any right under this license shall be assigned or otherwise transferred in violation of the provisions of the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974.This license is subject to the right of recapture or control by Section 108 of the Atomic Energy Act of 1954, as amended, and to all of the other provisions of said Acts, now or hereafter in effect and to all valid rules and regulations of the NRC.THIS LICENSES I^ALID UNLESS SIGNED BELOW BY AUTHORIZED N^ RpRESENTAT^E SIGNATURE:
DATE OF ISSUANCE:                           2-0if EXPORT LICENSE
(NAME AND TITLE Peter J. t^blghor^Acting Deputy Director Offi^ of International Programs DATE OF ISSUANCE:
 
2-0 if EXPORT LICENSE XMAT442 Page 2 of 2 OTHER U.S. PARTYflES)
XMAT442 Page 2 of 2 OTHER U.S. PARTYflES) TO EXPORT;
TO EXPORT;1. Cambridge Isotope Laboratories, inc.50 Frontage Road Andover, MA 01810 (Supplier/distributor)
: 1. Cambridge Isotope Laboratories, inc.
50 Frontage Road Andover, MA 01810 (Supplier/distributor)
: 2. Aldrich Chemical Co. LLC 6000 North Teutonia Avenue Milwaukee, Wl 53209 (Supplier/distributor)
: 2. Aldrich Chemical Co. LLC 6000 North Teutonia Avenue Milwaukee, Wl 53209 (Supplier/distributor)
: 3. Aldrich Chemical Co. LLC 3858 Benner Road Miamisburg, OH 45342 (Supplier/distributor)
: 3. Aldrich Chemical Co. LLC 3858 Benner Road Miamisburg, OH 45342 (Supplier/distributor)
: 3. Sigma Aldrich Fine Chemicals (SAFC)5485 County Road V Sheboygan Falls. Wl 53085 (Supplier/distributor)}}
: 3. Sigma Aldrich Fine Chemicals(SAFC) 5485 County Road V Sheboygan Falls. Wl 53085 (Supplier/distributor)}}

Latest revision as of 23:50, 20 October 2019

Export License Issued to Vertex Pharmaceuticals Incorporated, XMAT442
ML18156A453
Person / Time
Site: 11006299
Issue date: 06/04/2018
From: Peter Habighorst
NRC/OIP
To: Rothwell P
Vertex Pharmaceuticals Incorporated
Savoy J
References
Download: ML18156A453 (2)


Text

EXPORT LICENSE NRC FORM 250 (10-07)

NRC LICENSE NO.: XMAT442 UNITED STATES OF AMERICA Page 1 of 2 Nuclear Regulatory Commission NRC DOCKET NO.: 11006299 Washington, D.C. 20555 LICENSE EXPIRES June 30. 2023 Pursuant to the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974 and the regulations of the U.S. Nuclear Regulatory Commission (NRC) issued pursuant thereto, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued to the licensee authorizing the export of the materials and/or production or utilization facilities listed below, subject to the terms and conditions herein.

LICENSEE ULTIMATE CONSIGNEE(S)IN FOREIGN COUNTRY(IES)

Vertex Pharmaceuticals Incorporated F.I.S.- Fabbrica Italiana Sintetici S.p.A.

50 Northern Avenue Viale Milano Boston, MA 02210 26-36075 Montecchio Maggiore (Vicenza)

Italy Attn: Paula Rothwell (Manufacture active pharmaceutical ingredients for non-nuclear end use in clinical trials for the treatment of cystic fibrosis)

INTERMEDIATE CONSIGNEE(S)IN FOREIGN COUNTRY(IES) OTHER PARTY(IES) TO EXPORT NONE See Page 2 APPLICANT'S REFERENCE NO.: Appl. date 1/30/18 ULTIMATE DESTINATION(S): Italy QUANTITY(IES) DESCRIPTION OF MATERIAL(S) OR FACILITY(IES) 5,000 kilograms Deuterium in the form of deuterium gas, deuterium oxide, and deuterium compounds.

THIS LICENSES I^ALID UNLESS SIGNED BELOW Neither this license nor any right under this license shall be BY AUTHORIZED N^RpRESENTAT^E assigned or otherwise transferred in violation of the provisions of the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974. SIGNATURE: (

This license is subject to the right of recapture or control by Section 108 of the Atomic Energy Act of 1954, as amended, and to NAME AND TITLE Peter J. t^blghor^Acting Deputy Director all of the other provisions of said Acts, now or hereafter in effect Offi^ of International Programs and to all valid rules and regulations of the NRC.

DATE OF ISSUANCE: 2-0if EXPORT LICENSE

XMAT442 Page 2 of 2 OTHER U.S. PARTYflES) TO EXPORT;

1. Cambridge Isotope Laboratories, inc.

50 Frontage Road Andover, MA 01810 (Supplier/distributor)

2. Aldrich Chemical Co. LLC 6000 North Teutonia Avenue Milwaukee, Wl 53209 (Supplier/distributor)
3. Aldrich Chemical Co. LLC 3858 Benner Road Miamisburg, OH 45342 (Supplier/distributor)
3. Sigma Aldrich Fine Chemicals(SAFC) 5485 County Road V Sheboygan Falls. Wl 53085 (Supplier/distributor)